Drawing for TRIAD ACR IMAGE AND INFORMATION EXCHANGE

USPTO serial 86024766

TRIAD ACR IMAGE AND INFORMATION EXCHANGE

Reviewed by CopyMark Law Group

Reg. 4488594Status 710
Filing date
Status date
Registration date
Feb 25, 2014
Examiner
TRUSILO, KELLY JEAN
Law office
TMEG LAW OFFICE 107

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with TRIAD ACR IMAGE AND INFORMATION EXCHANGE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Andrew D. Price

ANDREW D. PRICE VENABLE LLPP.O. BOX 34385WASHINGTON, DC 20043-9998UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
009Computer software in the field of medical imaging, namely, software for the exchange of medical images and data for clinical research trials, accreditation, and data registries; computer software platforms in the field of medical imaging for the exchange of medical images and data for clinical research trials, accreditation, and data registriesSECTION 8 - CANCELLED—
042Platform as a service (PAAS) featuring computer software platforms in the field of medical imaging for the exchange of medical images and data for clinical research trials, accreditation, and data registriesSECTION 8 - CANCELLEDMar 2, 2012

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 9, 2024CAEXCANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9—
Feb 25, 2023REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Mar 2, 2020NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Mar 2, 2020C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Mar 2, 2020COC.CORRECTION UNDER SECTION 7 - PROCESSED—
Mar 2, 2020APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jan 22, 2020APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Nov 27, 2019E815TEAS SECTION 8 & 15 RECEIVED—
Nov 27, 2019ES7RTEAS SECTION 7 REQUEST RECEIVED—
Feb 25, 2014R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 10, 2013PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 20, 2013NPUBNOTICE OF PUBLICATION—
Nov 1, 2013PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Oct 31, 2013CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 24, 2013DOCKASSIGNED TO EXAMINER—
Aug 15, 2013AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Aug 14, 2013ALIEASSIGNED TO LIE—
Aug 8, 2013MDSCNOTICE OF DESIGN SEARCH CODE MAILED—
Aug 7, 2013TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 7, 2013PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Aug 7, 2013NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 3, 2013NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance